Clinical Trials Sponsored by Arnaud Jaccard

Total 251 results

Merck Sharp & Dohme LLC
Ariad Pharmaceuticals

Terminated

Extension Trial of Deforolimus (Ridaforolimus, MK-8669) in Participants With Advanced Cancer (MK-8669-038)

Advanced Cancers
M.D. Anderson Cancer Center
Ariad Pharmaceuticals

Withdrawn

Dose-Escalation Study of Ponatinib, a FLT3 Inhibitor, With and Without Combination of 5-Azacytidine, in Patients With FLT3-Mutated Acute Myeloid Leukemia (AML)

Leukemia | FLT3-Mutated Acute Myeloid Leukemia | FLT3-Mutated High-Risk Myelodysplastic Syndrome
Merck Sharp & Dohme LLC
Ariad Pharmaceuticals

Completed

Safety Study of AP23573 in Patients With Advanced, Refractory or Recurrent Malignancies (8669-013)(COMPLETED)

Lymphoma | Multiple Myeloma | Tumors

United States
Merck Sharp & Dohme LLC
Ariad Pharmaceuticals

Completed

Bicalutamide and Ridaforolimus in Men With Prostate Cancer (MK-8669-002)

Prostate Cancer
Merck Sharp & Dohme LLC
Ariad Pharmaceuticals

Completed

Safety, Tolerability and Maximum Tolerated Dose of Oral AP23573 in Combination With Doxorubicin (8669-015)

Sarcoma | Cancer
Merck Sharp & Dohme LLC
Ariad Pharmaceuticals

Completed

Ridaforolimus in Patients With Hepatic Insufficiency (MK-8669-046)

Hepatic Insufficiency | Healthy Volunteers
Merck Sharp & Dohme LLC
Ariad Pharmaceuticals

Completed

AP23573 in Female Adult Patients With Recurrent or Persistent Endometrial Cancer (8669-019)(COMPLETED)

Endometrial Cancer
Merck Sharp & Dohme LLC
Ariad Pharmaceuticals

Completed

Ridaforolimus in Treatment of Sarcoma-SUCCEED (Sarcoma Multi-Center Clinical Evaluation of the Efficacy of Ridaforolimus)(8669-011 AM6) (SUCCEED)

Metastatic Soft-Tissue Sarcomas | Metastatic Bone Sarcomas
Merck Sharp & Dohme LLC
Ariad Pharmaceuticals

Completed

Study of AP23573/MK-8669 (Ridaforolimus), A Mammalian Target of Rapamycin (mTOR) Inhibitor, in Participants With Advanced Sarcoma (MK-8669-018 AM1)(COMPLETED)

Sarcoma, Soft Tissue | Osteosarcoma | Leiomyosarcoma | Liposarcoma | Metastases
M.D. Anderson Cancer Center
Ariad Pharmaceuticals

Terminated

Ponatinib - Frontline for Chronic Myeloid Leukemia (CML) in Accelerated Phase (AP)

Leukemia

United States
Ariad Pharmaceuticals
United BioSource, LLC

Terminated

An Observational Registry to Evaluate the Incidence of and Risk Factors for Vascular Occlusive Events Associated With ICLUSIG® (OMNI)

Myeloid Leukemia, Chronic-Phase, Accelerated-Phase, Blast-Phase, Ph+ALL

United States
Merck Sharp & Dohme LLC
Ariad Pharmaceuticals

Completed

Ridaforolimus (AP23573/MK-8669) in Participants With Taxane-Resistant Androgen-Independent Prostate Cancer (AIPC)(MK-8669-017)

Prostate Cancer

United States
Merck Sharp & Dohme LLC
Ariad Pharmaceuticals

Completed

Safety Study of Ridaforolimus in Patients With Advanced, Refractory or Recurrent Malignancies (MK-8669-001 AM5)(COMPLETED)

Lymphoma | Multiple Myeloma | Tumors
Merck Sharp & Dohme LLC
Ariad Pharmaceuticals

Completed

Study of AP23573 in Patients With Relapsed or Refractory Hematologic Malignancies (8669-024)(COMPLETED)

Lymphoma | Myelodysplastic Syndromes | Leukemia | Hematologic Malignancies | Myeloid Metaplasia

United States
Merck Sharp & Dohme LLC
Ariad Pharmaceuticals

Completed

Safety Study of AP23573 in Patients With Progressive or Recurrent Glioma (8669-023)(COMPLETED)

Glioblastoma | Malignant Glioma | Gliosarcoma

United States
Merck Sharp & Dohme LLC
Ariad Pharmaceuticals

Completed

Study of Oral Ridaforolimus (AP23573, MK-8669) to Treat Patients With Refractory or Advanced Malignancies (MK-8669-016 AM4)(COMPLETED)

Cancer
Merck Sharp & Dohme LLC
Ariad Pharmaceuticals

Completed

A Combination Study With Ridaforolimus (MK8669) and Dalotuzumab (MK0646) in Patients With Advanced Cancer (8669-004)

Neoplasms
OHSU Knight Cancer Institute
Ariad Pharmaceuticals

No longer available

Compassionate Use Ponatinib

Chronic Myeloid Leukemia | Philadelphia Chromosome Positive (Ph+) Leukemias

United States
Susanne Arnold
Bristol-Myers Squibb

Completed

Paclitaxel, Carboplatin And Low Dose Radiation As Induction Therapy In Locally Advanced Head And Neck Cancer

Squamous Cell Carcinoma
ARNAS Civico Di Cristina Benfratelli Hospital

Not yet recruiting

a SIngle Center Study of Post-operative STEReotactic RAdiotherapY for Endometrial Cancer (SISTER-RAY)

Endometrial Cancer

Italy
GCS IHFB Cognacq-Jay
Fondation ARCAD

Active, not recruiting

TWICE-IRI: Optimization of Second-line Therapy With Aflibercept, Irinotecan (Day 1 or Day 1,3), 5-Fluorouracile and Folinic Acid in Patients With Metastatic Colorectal Cancer. A Randomized Phase III Study. (TWICE-IRI)

Metastasis | Cancer Colorectal

France
University of Colorado, Denver
Ariad Pharmaceuticals

Completed

Study of Ponatinib in Patients With Lung Cancer Preselected Using Different Candidate Predictive Biomarkers

Stage IIIA Non-small Cell Lung Cancer | Stage IIIB Non-small Cell Lung Cancer | Extensive Stage Small Cell Lung Cancer | Recurrent Small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer | Limited Stage Small Cell Lung Cancer | Adenocarcinoma of the Lung

United States
ARNAS Civico Di Cristina Benfratelli Hospital

Unknown

Kyphoplasty With Structured Titanium Spheres

Vertebral Fracture

Italy
Merck Sharp & Dohme LLC
Ariad Pharmaceuticals

Completed

Phase II Study of Ridaforolimus (MK-8669) With Metastatic Bone or Soft-tissue Sarcoma Patients (MK-8669-030 AM1)

Sarcoma
Merck Sharp & Dohme LLC
Ariad Pharmaceuticals

Completed

Trial of Deforolimus in Combination With Bevacizumab for Patients With Advanced Cancers (8669-010)(COMPLETED)

Solid Tumor
Merck Sharp & Dohme LLC
Ariad Pharmaceuticals

Terminated

A Study of Ridaforolimus in Non-Small Cell Lung Cancer (NSCLC) Patients With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutations (MK-8669-021 AM1)

Non-Small Cell Lung Cancer
Anand Jillella
Novartis Pharmaceuticals

Completed

Phase I Study of Panobinostat + Bortezomib for Relapsed and/or Refractory Mantle Cell Lymphoma (MCL) (BUS48T)

Mantle Cell Lymphoma

United States
Atos Medical AB
Instituto de Cancer Dr Arnaldo

Not yet recruiting

Long Term Effects of Heat and Moisture Exchangers (HMEs)

Laryngectomy; Status

Brazil
Susanne Arnold
Bristol-Myers Squibb

Completed

Paclitaxel, Carboplatin and Radiotherapy as Induction Therapy in Locally Advanced Head and Neck Cancer

Squamous Cell Carcinoma
Greenstar Social Maketing
Population Services International; David and Lucile Packard Foundation

Unknown

Integrating Family Planning With Immunization to Improve Maternal and Child Health

Contraception

Pakistan
Federation Francophone de Cancerologie Digestive
Fondation ARCAD

Recruiting

Phase III Study Evaluating Induction Chemotherapy Followed by Chemoradiotherapy Compared to Standard Chemoradiotherapy for Locally Advanced SCCA (KANALRAD)

Anal Cancer

France
GERCOR - Multidisciplinary Oncology Cooperative...
Fondation ARCAD

Recruiting

Efficacy of Neoadjuvant Chemotherapy in Terms of DFS in Patients With Localized Digestive Neuroendocrine Carcinomas (NEONEC)

Neuroendocrine Carcinoma | Digestive Cancer

France
Sheba Medical Center
Computational Imaging Lab , Dr. Arnaldo Mayer

Unknown

Positron Emission Tomography (PET) Images Using Deep Neural Networks

PET Images and Deep Neural Networks Algorithms

Israel
University of South Florida
The Arnold P. Gold Foundation

Completed

Effects of a Volunteer-based Lunch Program on Feelings of Loneliness in Elders

Depression | Anxiety | Loneliness | Aged

United States
Susanne Arnold
Eli Lilly and Company

Terminated

Phase I Trial of Biweekly Gemcitabine & Paclitaxel & Low-Dose Radiation for Metastatic or Recurrent Head & Neck Cancer

Head and Neck Cancer

United States
Hospital Universitari de Bellvitge
Hospital Arnau de Vilanova; Hospital Universitario 12 de Octubre

Completed

Evaluation of Nutritional Practices in the Critical Care (ENPIC)

Critical Illness | Intensive Care Unit | Nutritional Support

Spain
University of California, Davis
The Arnold P. Gold Foundation

Completed

Use of Theater to Invoke Empathy and Reduce Bias in Medical Students

Medical Student Bias

United States
Oregon Health and Science University
Laura and John Arnold Foundation

Completed

Pharmacists Expand Access to Reproductive heaLthcare (PEARL)

Contraception

United States
Susanne Arnold
Kentucky Lung Cancer Research Program

Completed

Effects of Carboplatin and Gemcitabine on Stage IIIB Pleural Effusion and Stage IV Lung Cancer

Stage IIIB Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer

United States
Universitat Internacional de Catalunya
Institut Català d'Oncologia; Hospital Arnau de Vilanova; Fundacion Rioja Salud

Not yet recruiting

Efficacy of a Proactive Approach to Death Thoughts in People With Advanced Cancer (Go-TAD)

Death | Advanced Cancer
Amy Arnold
American Heart Association

Terminated

Angiotensin 1-7 in Obesity Hypertension

Hypertension | Obesity

United States
Gynuity Health Projects
Planned Parenthood Federation of America; David and Lucile Packard Foundation

Completed

De-Medicalizing Mifepristone Medical Abortion

Medical Abortion

United States
Elizabeth Arnold
Patient-Centered Outcomes Research Institute

Recruiting

Preventing Suicide Among Sexual and Gender Diverse Young Adults in Primary Care in Texas

Suicidal Ideation | Suicide

United States
Susanne Arnold
United States Department of Defense

Completed

Study of Lung Cancer in Appalachian Kentucky: The Role of Environmental Carcinogens

Lung Cancer

United States
Susanne Arnold
Kentucky Lung Cancer Research Program

Terminated

Phase I Trial of Docetaxel and Low-Dose Fractionated Radiation in the Treatment of Metastatic or Recurrent NSCLC

Non-Small Cell Lung Cancer

United States
ARNA Genomics US Inc.
BIOMARKER-RU

Not yet recruiting

In Vitro Study of the Liquid Biopsy Test System of the Diagnostic Value, in Women With Various Forms of Breast Cancer (ARNABreast)

Breast Neoplasms
The University of Texas Health Science Center,...
Stanford University; Lucile Packard Children's Hospital

Unknown

Cycled Phototherapy: A Safer Effective Treatment for Small Premature Infants?

Hyperbilirubinemia | Extremely Low Birth Weight | Premature Newborns

United States
Cambridge Health Alliance
The Sandra and Arnold Gold Humanism Research Fund

Active, not recruiting

Community and Familial Impacts of the Opioid Crisis

Opioid Use Disorder | Bereavement | Overdose of Opiate

United States
ARNA Genomics US Inc.
BIOMARKER-RU

Recruiting

Retrospective Comparative in Vitro Case-controlled Study of the Liquid Biopsy Test System in Women With Breast Cancer

Breast Neoplasm Female

Russian Federation
University of Edinburgh
NHS Lothian; Marie Curie Hospice, Belfast; Accord Clinical Research

Completed

Exercise and Nutritional Rehabilitation in Patients With Cancer (ENeRgy)

Physical Activity | Diet Modification | Advanced Cancer | Cachexia; Cancer

United Kingdom

Clinical Trials Sponsored by Arnaud Jaccard

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Israel

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations